Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.
about
Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysisMulticentre prospective survey of SeHCAT provision and practice in the UK.Accelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers.MUBII-TB-DB: a database of mutations associated with antibiotic resistance in Mycobacterium tuberculosis.Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models.A 33-year-old Haitian immigrant with 7 months of abdominal pain and progressive distension.Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis.Interferon-gamma assay in combination with tuberculin skin test are insufficient for the diagnosis of culture-negative pulmonary tuberculosis.Differences between pediatric extra-pulmonary and pulmonary tuberculosis: a warning sign for the future.The impact of maternal infection with Mycobacterium tuberculosis on the infant response to bacille Calmette-Guérin immunization.The potential impact of BCG vaccine supply shortages on global paediatric tuberculosis mortality.Chronic Gastrointestinal Nematode Infection Mutes Immune Responses to Mycobacterial Infection Distal to the Gut.Improving Control of Tuberculosis in Low-Burden Countries: Insights from Mathematical Modeling.Recommendations for pediatric tuberculosis vaccination in ItalyTuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host GenotypeSystematic review of mathematical models exploring the epidemiological impact of future TB vaccines.The global burden of tuberculosis mortality in children: a mathematical modelling study.Modular programming for tuberculosis control, the "AuTuMN" platform.A review of clinical models for the evaluation of human TB vaccines.Modulation of Macrophage Responses by CMX, a Fusion Protein Composed of Ag85c, MPT51, and HspX from Mycobacterium tuberculosis.MTBVAC from discovery to clinical trials in tuberculosis-endemic countries.A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus.Clinical outcomes and direct costs after transcatheter aortic valve implantation in French centres: a longitudinal study of 1332 patients using a national database.Effectiveness of the First Dose of BCG against Tuberculosis among HIV-Infected, Predominantly Immunodeficient Children.Risk-benefit assessment of Bacillus Calmette-Guérin vaccination, anti-phenolic glycolipid I serology, and Mitsuda test response: 10-year follow-up of household contacts of leprosy patients.Problematic Dichotomization of Risk for Intensive Care Unit (ICU)-Acquired Invasive Candidiasis: Results Using a Risk-Predictive Model to Categorize 3 Levels of Risk From a Multicenter Prospective Cohort of Australian ICU Patients.British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.Designing Epitope Ensemble Vaccines against TB by Selection: Prioritizing Antigens using Predicted Immunogenicity.Exposure to human alveolar lining fluid enhances Mycobacterium bovis BCG vaccine efficacy against Mycobacterium tuberculosis infection in a CD8+ T-cell-dependent manner.Children with lymphadenitis associated with Bacillus Calmette-Guérin (BCG) vaccination do not experience more infections when compared with BCG-vaccinated children without lymphadenitis: a three years paired-cohort in Mexico.Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balance.Inter-individual variation in health and disease associated with pulmonary infectious agents.MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic.Tuberculosis updates 2018: Innovations and developments to end TB.Sex-related trends in mortality after elective abdominal aortic aneurysm surgery between 2002 and 2013 at National Health Service hospitals in England: less benefit for women compared with men.A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area.Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution.Next-Generation Vaccines Based on Bacille Calmette-Guérin.BCG vaccination in southern rural Mozambique: an overview of coverage and its determinants based on data from the demographic and health surveillance system in the district of Manhiça.BCG and Adverse Events in the Context of Leprosy.
P2860
Q22242062-295BE4F3-2C2D-4096-997A-20434373E448Q30382212-4CBF36BD-C1E2-4A31-ABA5-CC5E936A2419Q30403003-BC9C1AAD-D9C8-4E66-876E-359A454F7D4AQ33611361-872D5C36-66A9-4E25-B53B-2336C012CEE0Q33614952-C70CDEB8-FEC1-4D87-9A3A-8B18A7A8F6B1Q33879022-D613A87F-EA39-47CC-BCB6-42CA2F3636C2Q34146613-2C8A4210-E771-41BC-92FC-4FAD69B0094AQ34184039-2D5E2BDC-102E-4EA0-8E12-D329A2D49CC6Q34194155-D4B42E3C-293D-4E81-94C7-D3C3265ACE08Q35923817-A659FA51-A6E4-4C32-8168-6F6B6142D15CQ36135067-2075F6B6-7ED8-4602-8B50-101F16909871Q36597276-32A3AE4E-E430-4202-A661-B9B137CEF222Q36859680-21549ED9-5F8A-46FD-9F87-E78F2414BF7FQ37135291-04887012-FB06-485B-A49B-5B926A577E67Q37270954-B5D5976C-1D9F-434C-B9CD-80298EAB6104Q37473293-551F672A-74F4-4D79-9753-7875CD37163FQ38625418-B617770E-D539-4811-AEDD-45996D071D00Q38645894-A0C5A9A9-5D3B-4407-82C3-648AECC5A0E9Q38711772-A86B086F-9C54-4633-B630-4D974567B08CQ38959383-54E37365-1A2A-4FBB-902E-204C20817D83Q39266421-5A86FA88-8C17-4EFD-9D83-B9724650A459Q39362187-76FAC18D-1DE8-4E52-927A-E396A909A761Q39417014-4B820F8C-4BA7-4815-A1A1-474A7100D684Q39552628-26976202-69C7-4FC9-9BDC-08F543C233EBQ40202773-76E915D5-A994-4981-A3F5-101F88D716D6Q40549479-56E7D27D-217A-4F60-8EE3-5A5266FD764FQ40560650-FDB7905E-B741-4D11-8199-CB90A9165354Q41698245-5ABF74C4-538B-478A-9B6D-26C93F89B814Q41996136-FF620778-28F1-4DB2-A06F-D3C5651ECD02Q45247775-08EC339A-D409-4EBD-8DC2-CEE938BA63C5Q47287104-DD99C195-8E2B-4843-BB4A-FA48D475C552Q47550893-B2CB332F-E9E4-4CB5-91A7-5ED3E308640BQ47658864-0A4F1BA7-E17E-4477-A757-02E69627ADBDQ47674177-B1D8457F-7FDF-47D5-B388-F2C70A4E38A8Q48024292-D45FAE7C-7237-4283-81FD-EE03CD4E49C6Q48268531-61E914AA-A5FF-49C1-A312-2ACCDF418D6AQ48505883-91C73868-B075-4B15-806F-960B22AFF712Q49829375-E02EC20F-55F9-4300-AD14-60819660C603Q50032603-500FFABF-9D8F-4722-A39F-349F46A16BC1Q55264893-7C390811-0630-45E4-9A86-9F38ED779711
P2860
Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Systematic review and meta-ana ...... cination against tuberculosis.
@en
type
label
Systematic review and meta-ana ...... cination against tuberculosis.
@en
prefLabel
Systematic review and meta-ana ...... cination against tuberculosis.
@en
P2093
P50
P356
P1476
Systematic review and meta-ana ...... cination against tuberculosis.
@en
P2093
E Vynnycky
J M Watson
P E M Fine
P Mangtani
P304
1-372, v-vi
P356
10.3310/HTA17370
P577
2013-09-01T00:00:00Z